来自SARS-CoV-2的nsp14外核酶的活性向有修饰3'-Termini的RNA转向
S K Yuyukina1,2, A E Barmatov3, S N Bizyaev4,5,6
1Novosibirsk State University, Novosibirsk, Russia. sonyayuyukina@gmail.com.
Doklady. Biochemistry and biophysics
|June 20, 2023
概括
新的研究揭示了SARS-CoV-2 nsp14外核酶活性如何影响冠状病毒复制. 在RNA的修改.
科学领域:
- 病毒学 病毒学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 随着COVID-19的爆发,人们越来越需要有效的抗病毒疗法.
- 核类类似物是一种有前途的抗病毒药物,可以抑制病毒复制.
- 冠状病毒具有独特的校对机制,涉及具有3'→5'-外核酶活性的nsp14蛋白.
研究的目的:
- 为了研究SARS-CoV-2 nsp14外核酶的基质特异性和抑制潜力.
- 了解RNA的3'-终端区域的修改如何影响nsp14外核酶活性.
- 评估nsp10-nsp14复合体对外核酶功能的影响.
主要方法:
- 生物化学试验被用来测量SARS-CoV-2 nsp14对单链和双链RNA基质的水解.
- 合成和测试了在3'-终端区域具有各种修饰的RNA基质.
- 分析了单独的nsp14外核酶和与nsp10复合的活性.
主要成果:
- 在SARS-CoV-2 nsp14中,单链RNA主要通过双链RNA进行水解.
- 前末和末端核酸之间的二结的修改显著影响了nsp14外核酶活性.
- 该nsp10-nsp14复合体表现出与单独的nsp14相似的基质偏好和对修饰的敏感性.
结论:
- nsp14外核酶的活性是由RNA结构和特定的核酸修饰调节的.
- 了解这些相互作用对于设计针对冠状病毒的有效核类比基抗病毒药物至关重要.
- 准nsp14外核酶可能是开发新的COVID-19治疗方法的可行策略.
相关概念视频
Pre-mRNA Processing: Modification of pre-mRNA Ends
9.7K
In eukaryotic cells, transcripts made by RNA polymerase are modified and processed before exiting the nucleus. Unprocessed RNA is called precursor mRNA or pre-mRNA to distinguish it from mature mRNA.
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a cap to the 5' end of the growing transcript. In this process, a 5' phosphate is replaced by modified guanosine that has a methyl group attached (7-methyl guanosine). This 5' cap helps...
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a cap to the 5' end of the growing transcript. In this process, a 5' phosphate is replaced by modified guanosine that has a methyl group attached (7-methyl guanosine). This 5' cap helps...
9.7K
RNA Editing
9.1K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.1K
RNA Splicing
56.5K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.5K
Nuclear Export of mRNA
7.7K
Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
7.7K
Nonsense-mediated mRNA Decay
10.7K
The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
10.7K
Eukaryotic RNA Polymerases
24.4K
RNA Polymerase (RNAP) is conserved in all animals, with bacterial, archaeal, and eukaryotic RNAPs sharing significant sequence, structural, and functional similarities. Among the three eukaryotic RNAPs, RNA Polymerase II is most similar to bacterial RNAP in terms of both structural organization and folding topologies of the enzyme subunits. However, these similarities are not reflected in their mechanism of action.
All three eukaryotic RNAPs require specific transcription factors, of which the...
All three eukaryotic RNAPs require specific transcription factors, of which the...
24.4K


